Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Violi

Showing results (131-140 of 464) with videos related to

Pageof 47
Sort By:
The American Journal of Medicine|January 20, 2019
ABC (Atrial fibrillation Better Care) Pathway and Healthcare Costs in Atrial Fibrillation: The ATHERO-AF StudyDaniele Pastori, Alessio Farcomeni, Pasquale Pignatelli, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 10, 2016
NADPH Oxidase-2 and Atherothrombosis: Insight From Chronic Granulomatous DiseaseFrancesco Violi, Roberto Carnevale, Lorenzo Loffredo, et al.
Thrombosis and Haemostasis|May 22, 2015
Atrial fibrillation is not associated with increased risk of venous thromboembolism: Results from ARAPACIS studyStefania Basili, Marco Proietti, Francesco Perticone, et al.
European Journal of Internal Medicine|July 1, 2015
Lights and shadows in the management of old and new oral anticoagulants in the real world of atrial fibrillation by Italian internists. A survey from the Atrial Fibrillation Registry for Ankle-Brachial Index Prevalence Assessment-Collaborative Italian StudyPasquale Pignatelli, Daniele Pastori, Francesco Perticone, et al.
European Journal of Internal Medicine|December 28, 2020
The Atrial fibrillation Better Care (ABC) pathway and cardiac complications in atrial fibrillation: a potential sex-based difference. The ATHERO-AF studyDaniele Pastori, Danilo Menichelli, Francesco Violi, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 14, 2023
Statins under-treatment and mortality in patients with atrial fibrillation. Insights from the nationwide START registryDanilo Menichelli, Emilia Antonucci, Pasquale Pignatelli, et al.
Haematologica|February 1, 2020
Seronegative antiphospholipid syndrome: refining the value of "non-criteria" antibodies for diagnosis and clinical managementPasquale Pignatelli, Evaristo Ettorre, Danilo Menichelli, et al.
Mayo Clinic Proceedings|December 16, 2018
Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study CohortDaniele Pastori, Pasquale Pignatelli, Danilo Menichelli, et al.
Haematologica|March 31, 2022
Full <i>versus</i> prophylactic-intermediate doses of anticoagulants in COVID-19: a meta-analysisLorenzo Loffredo, Augusto Di Castelnuovo, Giovanni Alfonso Chiariello, et al.
Journal of Vascular Surgery|September 12, 2012
Effect on walking distance and atherosclerosis progression of a nitric oxide-donating agent in intermittent claudicationPaolo Gresele, Rino Migliacci, Enrico Arosio, et al.
Pageof 47

Showing results (131-140 of 464) with videos related to

Sort By:
Pageof 47
The American Journal of Medicine|January 20, 2019
ABC (Atrial fibrillation Better Care) Pathway and Healthcare Costs in Atrial Fibrillation: The ATHERO-AF StudyDaniele Pastori, Alessio Farcomeni, Pasquale Pignatelli, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 10, 2016
NADPH Oxidase-2 and Atherothrombosis: Insight From Chronic Granulomatous DiseaseFrancesco Violi, Roberto Carnevale, Lorenzo Loffredo, et al.
Thrombosis and Haemostasis|May 22, 2015
Atrial fibrillation is not associated with increased risk of venous thromboembolism: Results from ARAPACIS studyStefania Basili, Marco Proietti, Francesco Perticone, et al.
European Journal of Internal Medicine|July 1, 2015
Lights and shadows in the management of old and new oral anticoagulants in the real world of atrial fibrillation by Italian internists. A survey from the Atrial Fibrillation Registry for Ankle-Brachial Index Prevalence Assessment-Collaborative Italian StudyPasquale Pignatelli, Daniele Pastori, Francesco Perticone, et al.
European Journal of Internal Medicine|December 28, 2020
The Atrial fibrillation Better Care (ABC) pathway and cardiac complications in atrial fibrillation: a potential sex-based difference. The ATHERO-AF studyDaniele Pastori, Danilo Menichelli, Francesco Violi, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 14, 2023
Statins under-treatment and mortality in patients with atrial fibrillation. Insights from the nationwide START registryDanilo Menichelli, Emilia Antonucci, Pasquale Pignatelli, et al.
Haematologica|February 1, 2020
Seronegative antiphospholipid syndrome: refining the value of "non-criteria" antibodies for diagnosis and clinical managementPasquale Pignatelli, Evaristo Ettorre, Danilo Menichelli, et al.
Mayo Clinic Proceedings|December 16, 2018
Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study CohortDaniele Pastori, Pasquale Pignatelli, Danilo Menichelli, et al.
Haematologica|March 31, 2022
Full <i>versus</i> prophylactic-intermediate doses of anticoagulants in COVID-19: a meta-analysisLorenzo Loffredo, Augusto Di Castelnuovo, Giovanni Alfonso Chiariello, et al.
Journal of Vascular Surgery|September 12, 2012
Effect on walking distance and atherosclerosis progression of a nitric oxide-donating agent in intermittent claudicationPaolo Gresele, Rino Migliacci, Enrico Arosio, et al.
Pageof 47